DALRYMPLE & ASSOCIATES, LLC for EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION)

Defense DEF

Contracts and/or supply of the military for stockpiling and use of medical countermeasures including anthrax vaccine, IVIG, AIGIV, BIGIV, and chemical WMD decontamination and neutralization lotion (RSDL).

Contacted: Air Force, Dept of; White House Office; Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Defense Logistics Agency; Centers For Disease Control & Prevention (CDC); Defense Threat Reduction Agency (DTRA); Joint Chiefs of Staff; Natl Institutes of Health (NIH); Defense, Dept of (DOD); Homeland Security, Dept of (DHS); Health & Human Services, Dept of (HHS); Army, Dept of (Other)

Homeland Security HOM

Increased appropriations for CDC strategic national stockpile; increased appropriations for BARDA CBRN MCM advanced development; inceased appropriations for Project BioShield SRF; HR1300/S.1915-making anthrax vaccine available to 1st responders from the SNS prior to shelf live expiration for voluntary vaccination programs & HR 3299 for FDA priority review vouchers for developers of FDA approved MCMs against WMD CBRN threats.Contracting with CDC, HHS ASPR, BARDA and NIH for FDA licensed anthrax vaccine, botulinum antitoxin, AIGIV, BIGIV, VIGIV, third generation anthrax vaccine advanced development, RSDL for CHEMPACK,

Contacted: Army, Dept of (Other); White House Office; Defense, Dept of (DOD); Defense Threat Reduction Agency (DTRA); Health & Human Services, Dept of (HHS); Homeland Security, Dept of (DHS); Defense Logistics Agency; Food & Drug Administration (FDA); Natl Institutes of Health (NIH); SENATE; Centers For Disease Control & Prevention (CDC); Air Force, Dept of; HOUSE OF REPRESENTATIVES; Joint Chiefs of Staff

Bills named: S. 1915 (114th), H.R. 1300 (114th), H.R. 3299 (114th)